These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 15863556

  • 21. A critical assessment of preterm labor prevention strategies.
    Hueston WJ.
    J Fam Pract; 1992 Jul; 35(1):81-9. PubMed ID: 1613478
    [Abstract] [Full Text] [Related]

  • 22. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.
    Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
    [Abstract] [Full Text] [Related]

  • 23. A possible role for progesterone metabolites in human parturition.
    Sheehan PM.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):159-63. PubMed ID: 16638041
    [Abstract] [Full Text] [Related]

  • 24. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
    Rebarber A, Cleary-Goldman J, Istwan NB, Rhea DJ, Desch C, Russo-Stieglitz K, Saltzman DH.
    Am J Perinatol; 2008 May; 25(5):271-5. PubMed ID: 18401840
    [Abstract] [Full Text] [Related]

  • 25. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO, Stamilio DM, Macones GA, Polsky D.
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [Abstract] [Full Text] [Related]

  • 26. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
    de la Torre L, Istwan NB, Desch C, Rhea DJ, Roca L, Stanziano GJ, González-Quintero VH.
    Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
    [Abstract] [Full Text] [Related]

  • 27. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
    Rozenberg P.
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997
    [Abstract] [Full Text] [Related]

  • 28. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC, Mol BW, Bruinse HW.
    Ned Tijdschr Geneeskd; 2010 May; 154():A1730. PubMed ID: 20858311
    [Abstract] [Full Text] [Related]

  • 29. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM, Lewis DF.
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [Abstract] [Full Text] [Related]

  • 30. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL, Kauppila A, Tuimala R.
    Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
    [Abstract] [Full Text] [Related]

  • 31. The use of progestational agents for preterm birth: lessons from a mouse model.
    Elovitz MA, Mrinalini C.
    Am J Obstet Gynecol; 2006 Oct; 195(4):1004-10. PubMed ID: 17000233
    [Abstract] [Full Text] [Related]

  • 32. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
    Sanchez-Ramos L, Kaunitz AM, Delke I.
    Obstet Gynecol; 2005 Feb; 105(2):273-9. PubMed ID: 15684151
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The rebirth of progesterone in the prevention of preterm labor.
    Schmouder VM, Prescott GM, Franco A, Fan-Havard P.
    Ann Pharmacother; 2013 Apr; 47(4):527-36. PubMed ID: 23535817
    [Abstract] [Full Text] [Related]

  • 35. Perspectives in the prevention of premature birth.
    Ancel PY.
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov 15; 117 Suppl 1():S2-5. PubMed ID: 15530710
    [Abstract] [Full Text] [Related]

  • 36. Impact of prior gestational age at preterm delivery on effectiveness of 17-alpha-hydroxyprogesterone caproate in practice.
    González-Quintero VH, de la Torre L, Rhea DJ, Tudela CM, Vazquez-Vera E, Desch C, Istwan NB.
    Am J Obstet Gynecol; 2010 Sep 15; 203(3):257.e1-5. PubMed ID: 20678745
    [Abstract] [Full Text] [Related]

  • 37. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A, PREDICT Group.
    Ultrasound Obstet Gynecol; 2011 Sep 15; 38(3):281-7. PubMed ID: 21739499
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Risk screening for spontaneous preterm labour.
    Khan KS, Honest H.
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct 15; 21(5):821-30. PubMed ID: 17462957
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.